- Home
- PBYI vs OPBK Comparison
PBYI vs OPBK Comparison
Compare PBYI & OPBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBYI | OPBK |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 220.5M |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PBYI | OPBK |
|---|---|---|
| Price | $6.00 | $12.67 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | ★ 429.2K | 26.8K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.80% |
| EPS Growth | N/A | ★ 23.74 |
| EPS | 0.61 | ★ 1.72 |
| Revenue | ★ $27,685,000.00 | $3,204,000.00 |
| Revenue This Year | N/A | $16.07 |
| Revenue Next Year | N/A | $11.60 |
| P/E Ratio | $9.84 | ★ $7.37 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.58 | $10.43 |
| 52 Week High | $7.68 | $15.27 |
Technical Indicators
Market Signals| Indicator | PBYI | OPBK |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 35.97 |
| Support Level | $5.57 | $11.86 |
| Resistance Level | $6.15 | $12.75 |
| Average True Range (ATR) | 0.37 | 0.44 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 33.18 | 10.01 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About OPBK OP Bancorp
OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.